News items related to: Call to action
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Our partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
-
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
In an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
-
Open letter: Prepare NOW for equitable access to COVID-19 treatments in Eastern Europe and Central Asia
Organizations working on health and rights in the Eastern Europe and Central Asia (EECA) region, have called on governments to...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
Open letter: COVID-19 underlines the need for 37 World Trade Organization members to reverse a critical decision
As the International Treatment Preparedness Coalition (ITPC), we have signed an open letter asking 37 World Trade Organization members to...
-
Letter urges Gilead to ensure everyone can access its “promising” COVID-19 treatment pending clinical trial results
ITPC has joined the more than 150 civil society organizations and individuals expressing concerns in a letter to Gilead, coordinated...
-
Activists urge Indonesia’s govt to resolve HIV drugs shortage amid COVID-19 pandemic
We reported how stockouts, since January this year, have been leaving people living with HIV without their essential treatment in...
-
Civil society demands an end to ARV stockouts in Indonesia
Our partner, the Indonesian AIDS Coalition (IAC) is one of 73 organizations, calling on the country’s Ministry of Health to...
-
Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
A CAB meeting was held in Morocco, providing an opportunity to discuss access to treatment in a region facing an...
-
To achieve universal health coverage, people living with HIV and marginalized communities must be at the centre – says APN+
On Universal Health Coverage Day (12 December), our campaign partner the Asia Pacific Network of People Living with HIV (APN+)...